Pulmonary Medicine

Episodes 1-16 of 49

Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Project Oncology®
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
- Paola Marignani, PhD, EMBA
The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
Project Oncology®
The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
- John Cho, MD, PhD, FRCPC
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Project Oncology®
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
- Paola Marignani, PhD, EMBA
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Project Oncology®
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
- Ryan Quigley
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
Project Oncology®
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
- John Cho, MD, PhD, FRCPC
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Project Oncology®
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Long-Term Survival Data in High-Risk NSCLC: Insights from Real-World Practice
Long-Term Survival Data in High-Risk NSCLC: Insights from Real-World Practice
Project Oncology®
Long-Term Survival Data in High-Risk NSCLC: Insights from Real-World Practice
- Jacob Sands, MD
- Joshua K. Sabari, MD
Durable Outcomes in NSCLC: 6-Year Survival Findings from CheckMate 9LA
Durable Outcomes in NSCLC: 6-Year Survival Findings from CheckMate 9LA
Project Oncology®
Durable Outcomes in NSCLC: 6-Year Survival Findings from CheckMate 9LA
- Jacob Sands, MD
- Sandip Patel, MD
6-Year Outcomes from CheckMate 9LA: Efficacy and Safety Across NSCLC Subgroups
6-Year Outcomes from CheckMate 9LA: Efficacy and Safety Across NSCLC Subgroups
Project Oncology®
6-Year Outcomes from CheckMate 9LA: Efficacy and Safety Across NSCLC Subgroups
- Jacob Sands, MD
- Millie Das, MD
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Project Oncology®
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Assessing Nivolumab + Ipilimumab in mNSCLC: 6-Year Outcomes from CheckMate 9LA
Assessing Nivolumab + Ipilimumab in mNSCLC: 6-Year Outcomes from CheckMate 9LA
Project Oncology®
Assessing Nivolumab + Ipilimumab in mNSCLC: 6-Year Outcomes from CheckMate 9LA
- Jacob Sands, MD
- Martin Dietrich, MD, PhD
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Project Oncology®
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
- Balazs Halmos, MD, MS
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
Global Oncology Academy
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
- Gerard A. Silvestri MD, MS, Master FCCP
- Jeffrey B. Velotta, MD, FACS
- Anne Gonzalez, MD, M.Sc.
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Project Oncology®
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
- Balazs Halmos, MD, MS
Optimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
Optimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
Global Oncology Academy
Optimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
- Gerard A. Silvestri MD, MS, Master FCCP
- Fabien Maldonado, MD, FCCP
- Adam H. Fox, MD, MSc
Optimizing Immunotherapy for Advanced NSCLC: How to Manage Immune Toxicities
Optimizing Immunotherapy for Advanced NSCLC: How to Manage Immune Toxicities
Project Oncology®
Optimizing Immunotherapy for Advanced NSCLC: How to Manage Immune Toxicities
- Jacob Sands, MD
- Christine Bestvina, MD